Prophylactic Administration of Respiratory Syncytial Virus Immune Globulin to High-Risk Infants and Young Children
Open Access
- 18 November 1993
- journal article
- clinical trial
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 329 (21), 1524-1530
- https://doi.org/10.1056/nejm199311183292102
Abstract
Infants with cardiac disease or prematurity are at risk for severe illness caused by respiratory syncytial virus. Immune globulin with a high titer of antibodies against respiratory syncytial virus may offer infants and young children at risk protection from this serious, common respiratory illness.Keywords
This publication has 44 references indexed in Scilit:
- Respiratory syncytial virus-specific immunoglobulins in preterm infantsThe Journal of Pediatrics, 1993
- Intravenous immune globulin therapy for early-onset sepsis in premature neonatesThe Journal of Pediatrics, 1992
- Improved outcome of respiratory syncytial virus infection in a high-risk hospitalized population of Canadian childrenThe Journal of Pediatrics, 1992
- Early ribavirin treatment of respiratory syncytial viral infection in high-risk childrenThe Journal of Pediatrics, 1990
- Role of respiratory syncytial virus in early hospitalizations for respiratory distress of young infants with cystic fibrosisThe Journal of Pediatrics, 1988
- Risk of respiratory syncytial virus infection for infants from low-income families in relationship to age, sex, ethnic group, and maternal antibody levelThe Journal of Pediatrics, 1981
- Neonatal Respiratory Syncytial Virus InfectionNew England Journal of Medicine, 1979
- Apnea associated with respiratory syncytial virus infection in young infantsThe Journal of Pediatrics, 1977
- The association of viral and bacterial respiratory infections with exacerbations of wheezing in young asthmatic childrenThe Journal of Pediatrics, 1973
- Studies on the role of viruses, bacteria, and M. pneumoniae as causes of lower respiratory tract infections in childrenThe Journal of Pediatrics, 1968